EUVIMED · CrossrefZeitschrift
Oncology Times
ISSN 0276-2234 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Trial Shows Smoking Persists During & After Cancer Treatment
IL1RAP to Overcome Treatment Resistance in Pancreatic Cancer
Remote Smoking Cessation Program Doubled Quit Rate for Cancer Patients
Adjuvant Selpercatinib Cuts Recurrence 83% in RET Fusion-Positive Lung Cancer
Harnessing Artificial Intelligence to Improve Cancer Care
Single-Fraction SBRT Shows 3-Year Disease Control in Prostate Cancer
Sildenafil Restricts Metastasis by Cutting Off Cancer Cells' Cholesterol Supply
Expanded Scope of Artificial Intelligence in Lung Cancer Imaging
FDA Finalizes Guidance to Broaden Cancer Clinical Trial Eligibility
ACOG Expands Role of Surgery in Ovarian Cancer Prevention
Daraxonrasib Approval Marks a Major Advance in Pancreatic Cancer
An Assortment of Journal Abstracts to Enhance Oncology Care
Immunotherapy Improves Survival in Localized Prostate Cancer
Personalized mRNA Vaccine Reduces Recurrence in Melanoma
Fructose Metabolism Linked to Ovarian Cancer Dissemination
Targeting an Inflammatory Enzyme Might Prevent Lung Cancer
Review Details Treatment Decisions Guided by Risk in Multiple Myeloma
Building a Bispecific Antibody Cancer Program
How Geriatric Assessment Can Help Better Guide Dose Modification in Older Adults With Cancer
FDA Updates Highlighting the Latest Cancer Treatments
Shop Talk
UpToDate®
Managing Insomnia in Breast Patients Undergoing Chemotherapy
Trust: The Next Needed Breakthrough in Colorectal Cancer
NCCN Updates Guidelines to Improve Care for Hereditary Cancer Patients
Novel Antibody-Drug Conjugate Shows Promise in Advanced Gastric Cancer
Film Dressing Reduces Acute Radiation Dermatitis in Breast Cancer
Melphalan Flufenamide (Pepaxto®)
The Four Colorectal Cancer Consensus Molecular Subtypes
UpToDate®
EUVIMED